Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar;8(5):234. doi: 10.21037/atm.2019.12.158

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2020 Annals of Translational Medicine. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Differences between complete response (CR) end points (between fosaprepitant regimen and aprepitant regimen) during the 120 hours after chemotherapy administration (error bars, 95% CI). CR is defined as no vomiting and no use of rescue medication. Overall phase was 0 to 120 hours after initiation of chemotherapy. Delayed phase was 25 to 120 hours after initiation of chemotherapy. 95% CIs were around the difference in response rates calculated by the Miettinen and Nurminen method. Dashed line represents prespecified lower bound of 95% CI for noninferiority.